Assignee
TEVA PHARMACEUTICALS USA INC F
0 granted patents·15 pending applications·0 citations·filing 2005–2008
Top patents by PatentIndex Score
15 records- 0168US2008300409A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0268US2008306268A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0366US2008214835A1Processes for preparing darifenacin hydrobromideTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0465US2008090835A1Polymorphic forms of ziprasidone HCl and processes for their preparationTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 0564US2008045707A1Processes for the preparation of linezolid intermediateTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 0664US2008214846A1Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0763US2009187022A1Crystalline clopidogrel hydrobromide and processes for preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0863US2008319191A1Crystalline form IV of linezolidTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0962US2008132579A1Preparation of levalbuterol hydrochlorideTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 1062US2008216562A1Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 1161US2010278912A1Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the compositionTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 1261US2007072868A1Novel synthesis of gatifloxacinTEVA PHARMACEUTICALS USA INC F·Filed 2006·Application pending·0 cites
- 1357US2006293363A1Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazolesTEVA PHARMACEUTICALS USA INC F·Filed 2006·Application pending·0 cites
- 1457US2005288301A1Novel crystalline forms of gatifloxacinTEVA PHARMACEUTICALS USA INC F·Filed 2005·Application pending·0 cites
- 1556US2008200532A1Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using themTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TEVA PHARMACEUTICALS USA INC F files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →